15 research outputs found
The Effectiveness of the Army Medical Command Tobacco Cessation Regulation on Self-Reported Tobacco Quit Rates of Soldiers
On the 4th of March, 2013, LTG Patricia D. Horoho, then the Surgeon General and Commanding General of the United States Army Medical Command (MEDCOM) published the Army Medicine 2020 Campaign Plan. The plan incorporates three different methods to take action within MEDCOM. These are to: “Increase Capacity, Enhance Diplomacy and Improve Stamina” (Army Medicine 2020 Campaign Plan; “Extension”). Within the “Improve Stamina” component of the plan, Campaign Objective 3-3 is to “Increase Healthy Behavior.” Specifically detailed within this section is to promote tobacco-free living under sub-objective 3-3.1. This sub-objective seeks to establish a change in culture throughout the United States Army: decreasing use and subsequently reducing the tobacco-related morbidity and mortality in Soldiers, retirees and their families. One specific method mentioned in the 2020 Campaign Plan is to establish more tobacco-free areas both in Army Medical Treatment Facilities (MTF) as well as locations on Army installations. Going one step further, the MEDCOM issued an Operations Order (Medical Command Tobacco Free Living Operations Order 15-48, 8 May 15), which took effect on 1 April, 2016, which not only mandated tobacco-free MTFs, but also states that all MEDCOM Soldiers are not authorized to use tobacco products (including e-cigarettes) while on duty or in uniform. Although many businesses including hospitals throughout the United States have enacted tobacco-free workplaces and campuses, never before has this requirement extended beyond the range of the campus itself. It can be readily assumed that the scope of a regulation of this nature will have far-reaching effects on improving the health of staff through enforcing a change in culture in much of its workforce. This research will determine what effects the new policy has on MEDCOM Soldiers over a short term in an effort to ascertain the future potential for this policy and others to be based upon it. Need for the Study: The United States Centers for Disease Control and Prevention (CDC) estimates that 21.3% of adults in the United States use tobacco products either every day or some days (Hu et al 2016). Of these, the greatest users were in the 18-24 year old male category. Tobacco use has been found to be the cause of approximately 480,000 American deaths per year, with health costs approaching 156 billion in lost productivity (“Tobacco Use,” 2016). Although tobacco use has gone down in the United States over the last fifty years, it is still attributed to 5%-14% of all U.S. healthcare dollars spent per year (Xu, Bishop, Kennedy, Simpson, & Pechaecek, 2015). Furthermore, Xu et al explains that based on the 2006-2010 Medical Expenditure Panel Survey (MEPS), approximately 32.8% of spending from federal health insurance programs (including the Veterans Affairs, Indian Health, and military treatment facilities) was directed toward cigarette smoking related illness. The United States CDC found that smoking in the military is higher than that of the general population on the whole. In 2008, approximately 31% of all Active Duty military were smokers (Bray et al, 2010). In 2011, 24% of Active military smoked compared with 19% of civilians, and from the period of 2007-2010 male veterans were 5% more likely than nonveterans to be smokers (“Current Cigarette Smoking Among U.S. Adults Aged 18 Years and Older,” 2016). According to GlobalSecurity.org (2016), there were approximately 1,301,300 total members of the Active United States military in 2016. This would mean that as many as 312,312 personnel could be smoking in the active duty. The financial and lost work hours of this are significant. In September, 2015, the Veterans Affairs projected a total Veteran population of 21,681,000 (“Department of Veterans Affairs Statistics at a Glance,” 2016). The five percent difference as mentioned above equates to over a million Veterans who are more likely to smoke than their civilian counterparts, which by extension increases the cost to care for these Veterans. The size of the Veteran population continues to grow as new military retirees enter the system, and modern medicine increases the lifespan of those currently enrolled in the system. Lastly, although an older study, Robert Klesges et al (2000) presented statistics on the effects of smoking on military training. The researchers specifically looked at the relationship between smoking and early discharges from the United States Air Force. It was found that of 29,044 personnel entering the Air Force between August, 1995 and August, 1996, smokers were found to be 1.8 times more likely to be prematurely discharged than non-smokers. This equated to 629 Airmen being discharged for problems related to smoking, costing the Air Force in excess of 133 million, which approached 1% of the total military training budget. The effects of tobacco use in the United States military plays a significant impact on multiple levels. The impact on health from tobacco use has potential effects from the individual Soldiers and their families’ health, through the unit level and on to the readiness of the entire Army. The direct effects of smoking and tobacco on the individual, and smoking-related illness resulting in lost work time has been well documented by numerous studies. In addition, the effects of second-hand smoke on the general population and on the families of smokers has also been noted. Because of the extremely physical nature of many of the career fields in the Army, any loss of physical capacity equates to a decrease in job performance and a degradation in capability to accomplish assigned missions. This results in a direct impact from tobacco. Lastly, due to the nature of military health insurance, which covers 100% of a Soldier’s and family’s care, there is the direct financial impact on caring for the sequelae of tobacco use, with the additional impact of sick time taken by the Soldier, keeping them from being able to support the unit and their mission. Problem Statement: Although the evidence is apparent for the inherent health risks from tobacco use, quit rates in tobacco users are historically low, with a high degree of recidivism back to tobacco use. The Active Duty Army, in having authority to dictate policies to affect their employees (Soldiers) has the potential to influence tobacco use through policies making it “illegal” to use tobacco during the duty day. The purpose of this study is to assess whether the MEDCOM policy against tobacco use results in greater tobacco quit rates among MEDCOM Soldiers, in comparison to the same sample of Soldiers prior to the implementation of the new MEDCOM tobacco use policy. Specific Aim 1: What are the current statistics of tobacco use in the United States Army at this time, in comparison to the American population-at-large? Specific Aim 2: Is there a difference in tobacco quit rates in MEDCOM Soldiers after implementation of the 2016 Tobacco Cessation Policy? Population The population to be considered by this study includes all Active Duty Soldiers stationed on a large Army installation between October 2015 and October 2016, which includes sample data from before and after policy implementation. Hypotheses: The primary goal of the MEDCOM tobacco policy is to reduce the number of Soldiers using tobacco. Thus, the aim of this study will be to examine the use rates and quit rates before and after the implementation of the new tobacco policy. Through accessing data from routine appointments, the following hypotheses will be studied: Hypothesis 1: There is no difference in tobacco use following implementation of the new MEDCOM tobacco policy, in comparison to prior to the policy implementation. Hypothesis 2: There is no difference in tobacco use between MEDCOM Soldiers and non-MEDCOM Soldiers following the implementation of the new tobacco policy
Secondary Traumatic Stress:Prevalence and Symptomology Amongst Detective Officers Investigating Child Protection Cases
136 Long-term Supratentorial Radiographic Effects of Surgery and Local Radiation in Children with Infratenorial Ependymoma
Active device technologies
A varactor is a nonlinear reactive device used for harmonic generation, parametric amplification, mixing, detection, and voltage-variable tuning. However, present applications of varactors are mostly for harmonic generation at millimeter and submillimeter wave frequencies, and as tuning elements in various microwave applications. Varactors normally exhibit a voltage-dependent capacitance and can be fabricated from a variety of semiconductor materials
The nested chinese restaurant process and bayesian nonparametric inference of topic hierarchies
Risk of Epidural Hematoma after Neuraxial Techniques in Thrombocytopenic Parturients : A Report from the Multicenter Perioperative Outcomes Group
BACKGROUND:: Thrombocytopenia has been considered a relative or even absolute contraindication to neuraxial techniques due to the risk of epidural hematoma. There is limited literature to estimate the risk of epidural hematoma in thrombocytopenic parturients. The authors reviewed a large perioperative database and performed a systematic review to further define the risk of epidural hematoma requiring surgical decompression in this population. METHODS:: The authors performed a retrospective cohort study using the Multicenter Perioperative Outcomes Group database to identify thrombocytopenic parturients who received a neuraxial technique and to estimate the risk of epidural hematoma. Patients were stratified by platelet count, and those requiring surgical decompression were identified. A systematic review was performed, and risk estimates were combined with those from the existing literature. RESULTS:: A total of 573 parturients with a platelet count less than 100,000 mm who received a neuraxial technique across 14 institutions were identified in the Multicenter Perioperative Outcomes Group database, and a total of 1,524 parturients were identified after combining the data from the systematic review. No cases of epidural hematoma requiring surgical decompression were observed. The upper bound of the 95% CI for the risk of epidural hematoma for a platelet count of 0 to 49,000 mm is 11%, for 50,000 to 69,000 mm is 3%, and for 70,000 to 100,000 mm is 0.2%. CONCLUSIONS:: The number of thrombocytopenic parturients in the literature who received neuraxial techniques without complication has been significantly increased. The risk of epidural hematoma associated with neuraxial techniques in parturients at a platelet count less than 70,000 mm remains poorly defined due to limited observations
Risk of Epidural Hematoma after Neuraxial Techniques in Thrombocytopenic Parturients : A Report from the Multicenter Perioperative Outcomes Group
BACKGROUND:: Thrombocytopenia has been considered a relative or even absolute contraindication to neuraxial techniques due to the risk of epidural hematoma. There is limited literature to estimate the risk of epidural hematoma in thrombocytopenic parturients. The authors reviewed a large perioperative database and performed a systematic review to further define the risk of epidural hematoma requiring surgical decompression in this population. METHODS:: The authors performed a retrospective cohort study using the Multicenter Perioperative Outcomes Group database to identify thrombocytopenic parturients who received a neuraxial technique and to estimate the risk of epidural hematoma. Patients were stratified by platelet count, and those requiring surgical decompression were identified. A systematic review was performed, and risk estimates were combined with those from the existing literature. RESULTS:: A total of 573 parturients with a platelet count less than 100,000 mm who received a neuraxial technique across 14 institutions were identified in the Multicenter Perioperative Outcomes Group database, and a total of 1,524 parturients were identified after combining the data from the systematic review. No cases of epidural hematoma requiring surgical decompression were observed. The upper bound of the 95% CI for the risk of epidural hematoma for a platelet count of 0 to 49,000 mm is 11%, for 50,000 to 69,000 mm is 3%, and for 70,000 to 100,000 mm is 0.2%. CONCLUSIONS:: The number of thrombocytopenic parturients in the literature who received neuraxial techniques without complication has been significantly increased. The risk of epidural hematoma associated with neuraxial techniques in parturients at a platelet count less than 70,000 mm remains poorly defined due to limited observations